Skip to main content
Clinical Trials/NCT00593229
NCT00593229
Terminated
Not Applicable

An Observational Study of All Forms of Thrombotic Microangiopathy in Pediatric Patients

Northwell Health1 site in 1 country6 target enrollmentJanuary 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thrombotic Microangiopathy
Sponsor
Northwell Health
Enrollment
6
Locations
1
Primary Endpoint
Determine genetic causes of TMA
Status
Terminated
Last Updated
12 years ago

Overview

Brief Summary

This registry will collect clinical data and store biosamples (seru, plasma, urine, and DNA) annually from pediatric patients with thrombotic mcroangiopathy

Detailed Description

Children age, 6 months - 18 years, are eligible if they have one of the following categories of thrombotic microangiopathy (TMA):(1) severe D+HUS; (2) non-familial atypical HUS; (3) familial atypical HUS; or (4) TTP Patients are seen intially and annually thereafter Biosamples are collected for storage annually.

Registry
clinicaltrials.gov
Start Date
January 2007
End Date
October 2011
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Severe HUS, familial or non-familial atypical HUS, TTP

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Determine genetic causes of TMA

Time Frame: Ongoing

Determine epidemiology and outcomes of the various forms of TMA

Time Frame: Ongoing

Secondary Outcomes

  • Initiate clinical trials in TMA(In the future)

Study Sites (1)

Loading locations...

Similar Trials